Method and composition for treating and preventing pathogenic effects caused by intracellular calcium overload
AssigneeLeigh Biotechnology, Inc.
InventorsRobert D. Pearlstein, Richard S. Kramer
Life of this patent
Estimating the term…
Loading patent…
AssigneeLeigh Biotechnology, Inc.
InventorsRobert D. Pearlstein, Richard S. Kramer
Estimating the term…
The present invention provides a method and composition for treating or preventing pathogenic effects in a mammal caused by intracellular calcium overload, comprising administering to a mammal a mixture of sodium co-transport dependent amino carboxylic acids or their physiologically acceptable salts in an amount sufficient to substantially saturate sodium-dependent amino carboxylic acid transport mechanisms of a cell's plasma membranes. Administration of these amino carboxylic acids can advantageously treat or prevent cell lysis and irreversible cell damage caused by intracellular calcium overload, especially in mammals suffering from a disease condition associated with or resulting from insufficient tissue oxygenation.
A method for treating or preventing pathogenic effects in a mammal caused by intracellular calcium overload, comprising administering to the mammal a mixture of sodium co-transport dependent amino carboxylic acids or their physiologically acceptable salts in an amount sufficient to substantially saturate the sodium-dependent transport mechanisms of a cell's plasma membrane.
A pharmaceutical composition for treating or preventing pathogenic effects in a mammal caused by intracellular calcium overload comprising a mixture of sodium co-transport dependent amino carboxylic acids or their physiologically acceptable salts in an amount sufficient to substantially saturate the sodium-dependent transport mechanism of a cell's plasma membrane and treat or prevent said pathogenic effects, together with a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.